comparemela.com

Braf Mutations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Understanding the Impact of COSMIC-311 and Sequencing in DTC

Marcia Brose, MD, examines data from the COSMIC-311 study, emphasizing the importance of promptly initiating second-line therapy for patients who have progressed on first-line treatments.

Optimizing therapyCosmic 311Braf mutationsBraf inhibitorBraf v600eTumor shrinkageOcular toxicitiesCardiac toxicities

Deciding Between Melanoma Therapy Options

A panel of skin cancer experts share their thoughts on treatment selection for patients with melanoma.

Sunandana chandraAnnac pavlickNikhil khushalaniUnresectable metastatic melanomaCombination immunotherapyAnti pd 1Braf mutationsTriplet therapyBraf mek inhibitorCheckmate 067

vimarsana © 2020. All Rights Reserved.